Ampio Pharmaceuticals, Inc. (AMPE)
NYSEAMERICAN: AMPE · IEX Real-Time Price · USD
0.820
+0.008 (1.05%)
At close: Mar 27, 2024, 4:00 PM
0.850
+0.030 (3.66%)
Pre-market: Mar 28, 2024, 4:00 AM EDT

Ampio Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2007
Selling, General & Admin
7.0811.478.676.665.954.365.266.549.068.96
Upgrade
Research & Development
2.448.9211.99.1712.626.8310.4210.5515.1122.49
Upgrade
Other Operating Expenses
0.061.9400000000
Upgrade
Operating Expenses
9.5722.3220.5715.8318.5811.1815.6817.0824.1731.45
Upgrade
Operating Income
-9.57-22.32-20.57-15.83-18.58-11.18-15.68-17.08-24.17-31.45
Upgrade
Interest Expense / Income
000000.01-0000
Upgrade
Other Expense / Income
-0.94-5.98-3.50.06-4.95-45.1836.222.08-0.06-0.14
Upgrade
Pretax Income
-8.63-16.34-17.08-15.89-13.6333.99-51.89-19.16-24.11-31.31
Upgrade
Net Income
-8.63-16.34-17.08-15.89-13.6333.99-51.89-19.16-24.11-31.31
Upgrade
Shares Outstanding (Basic)
1111000000
Upgrade
Shares Outstanding (Diluted)
1111000000
Upgrade
Shares Change
7.50%10.31%18.57%31.81%43.96%39.50%21.43%3.43%3.51%31.16%
Upgrade
EPS (Basic)
-10.66-21.68-25.80-27.00-30.00137.99-236.99-108.00-185.99-227.99
Upgrade
EPS (Diluted)
-10.66-29.32-30.20-27.00-42.00-36.00-236.99-108.00-185.99-227.99
Upgrade
Free Cash Flow
-8.56-21.13-14.19-14.79-15.41-12.7-11.48-14.63-26.55-39.41
Upgrade
Free Cash Flow Per Share
-10.57-28.04-21.35-25.67-35.38-51.95-52.74-81.63-153.22-235.36
Upgrade
EBITDA
-8.51-15.29-15.98-14.72-12.3635.27-50.68-17.95-23.28-30.96
Upgrade
Depreciation & Amortization
0.121.051.091.181.271.281.211.210.820.34
Upgrade
EBIT
-8.63-16.34-17.08-15.89-13.6333.99-51.9-19.16-24.11-31.31
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).